期刊文献+

冠心病患者阿司匹林抵抗相关因素分析 被引量:3

Correlative factors analysis of aspirin resistance in patients with coronary heart disease
原文传递
导出
摘要 目的:探讨冠心病患者阿司匹林抵抗(AR)的发生率,并对其临床相关因素进行分析。方法:选择264例正规服用阿司匹林(75~100mg/d)超过1个月的冠心病患者,分别用胶原(COL)和二磷酸腺苷(ADP)作为诱导剂测定其静脉血中血小板聚集功能,根据结果分为AR组、阿司匹林半抵抗(ASR)组和阿司匹林敏感(AS)组,分析各组间的临床特征,找出可能与AR有关的因素。结果:所有入选者中AR发生率为8.71%(23/264),ASR发生率为18.56%(49/264),AR+ASR总发生率27.27%。AR组、ASR组中,女性和伴糖尿病者及外周血小板计数较AS组高(P<0.05)。结论:冠心病患者AR+ASR的总发生率为27.27%,其发生可能与性别、伴糖尿病以及外周血小板数目有关。 Objective:To investigate the incidence and correlative factors of aspirin resistance (AR) in the patients with coronary heart disease. Method:We enrolled 264 patients with coronary heart disease who had taken aspirin regularly (75-100 mg/d) for more than one month.Platelet aggregation function induced by adenosine diphosphate(ADP)and collagen(COL)were determined by whole blood impedance method.According to the results,all patients were divided into three groups: aspirin resistance(AR) group,aspirin semiresponder (ASR) group and AS group. Differences of clinical characteristics among these groups were analyzed to find the correlative factors of AR. Result:The incidence of AR and ASR were 8.71% (23/264) and 18.56% (49/264),the total incidence was 27.27%. The percent of female and diabetes mellitus,and the count of platelet (PLT) in these groups were higher in AR or ASR group than those in AS group (P〈0.05). Conclusion:The incidence of AR plus ASR in patients with coronary heart disease was 27.27%. AR is likely correlated with sex,the counts of PLT and diabetes mellitus.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2009年第9期667-670,共4页 Journal of Clinical Cardiology
关键词 冠状动脉疾病 阿司匹林抵抗 相关因素 coronary disease aspirin resistance correlative factors
  • 相关文献

参考文献10

二级参考文献51

  • 1黄尉国,王鸿利,张颖琪,朱立红,李耀辉,王学锋,程寅琳,邵慧珍,张鲁,葛维成.血浆D-二聚体检测及其临床应用[J].中华医学检验杂志,1995,18(2):71-74. 被引量:318
  • 2张妍,梁静,周玉杰,袁慧,张永志,董磊.服用阿司匹林后血小板聚集功能对介入治疗后心肌坏死指标的影响[J].中华心血管病杂志,2005,33(8):695-699. 被引量:8
  • 3陈世德,陶新智.慢性心力衰竭患者血浆血小板功能及纤溶活性的变化[J].临床心血管病杂志,2007,23(8):622-623. 被引量:6
  • 4Patrono C,Bachmann F,Baigent C,et al.European Society of Cardiology.Expert consensus document on the use of antiplatelet agents.The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.Eur Heart J,2004,25:166-181. 被引量:1
  • 5Eagle KA,Guyton RA,Davidoff R,et al.American College of Cardiology.American Heart Association Task Force on Practice Guidelines.American Society for Thoracic Surgery and the Society of Thoracic Surgeons.ACC/AHA 2004 guideline update for coronary artery bypass graft surgery:summary article:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery).Circulation,2004,110:1168-1176. 被引量:1
  • 6Stein PD,Alpert JS,Bussey HI,et al.Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves.Chest,2001,119:2205-2275. 被引量:1
  • 7Chen ZM,Jiang LX,Chen YP,et al.COMMIT (ClOpidogrel and Metoprolol in Myocardial Infarction Trial) collaborative group.Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction:randomised placebo-controlled trial.Lancet,2005,366:1607-1621. 被引量:1
  • 8Patrono C,Coller B,FitzGerald GA,et al.Platelet-active drugs:the relationships among dose,effectiveness,and side effects:the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.Chest,2004,126(3 Suppl):234S-264S. 被引量:1
  • 9Pearson TA,Blair SN,Daniels SR,et al.AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke:2002 Update:Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases.American Heart Association Science Advisory and Coordinating Committee.Circulation,2002,106:388-391. 被引量:1
  • 10Ridker PM,Cook NR,Lee IM,et al.A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.N Engl J Med,2005,352:1293-1304. 被引量:1

共引文献221

同被引文献23

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部